Progressive Pulmonary Artery Dilatation is Associated with Type B Aortic Dissection in Patients with Marfan Syndrome

Christel Brouwer1, Haldun Bulut2, Willemijn van Gemert3

  • 1Department of Radiology and Nucleair Imaging, Radboud University Medical Center, Nijmegen 6500 HB, the Netherlands. brouwer.christel@gmail.com.

Abstract

Insights

Progressive pulmonary artery (PA) dilatation is associated with type B aortic dissection in Marfan syndrome (MFS) patients. This finding highlights the importance of monitoring PA dimensions in MFS for cardiovascular risk assessment.

Area of Science:

  • Cardiovascular Medicine
  • Genetics and Inherited Diseases
  • Radiology and Imaging

Background:

  • Marfan syndrome (MFS) is a genetic connective tissue disorder.
  • MFS significantly increases cardiovascular morbidity and mortality, particularly due to aortic complications.
  • The relationship between aortic complications and pulmonary artery (PA) dilatation in MFS is not well understood.

Purpose of the Study:

  • To investigate the association between progressive pulmonary artery (PA) dilatation and aortic complications in patients with Marfan syndrome.
  • To determine if PA dilatation is a predictor of dissection in MFS.
  • To assess the clinical significance of PA dimensions in MFS management.

Main Methods:

  • Retrospective analysis of magnetic resonance imaging (MRI) data from 162 Marfan syndrome patients.
  • Measurement of PA diameter at baseline and during follow-up (mean 8.6 years).
  • Definition of PA dilatation as a ≥2 mm increase in diameter; correlation with dissection events.

Main Results:

  • 44% (71/162) of patients exhibited progressive PA dilatation.
  • A significantly higher prevalence of PA dilatation was observed in patients with aortic dissection (64%) compared to those without (39%).
  • PA dilatation was independently associated with type B aortic dissection (OR 1.85; p=0.02), while descending aorta diameter was not.

Conclusions:

  • Progressive pulmonary artery dilatation is associated with type B aortic dissection in Marfan syndrome.
  • These findings suggest that PA dimensions should be closely monitored in MFS patients.
  • Further research into the role of PA dimensions in MFS cardiovascular risk stratification is warranted.

Related Concept Videos

Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
241
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
344
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
164
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
415
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
343
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
324